Table of Contents Author Guidelines Submit a Manuscript
Journal of Aging Research
Volume 2017, Article ID 6026358, 8 pages
https://doi.org/10.1155/2017/6026358
Research Article

Polypharmacy among Underserved Older African American Adults

1Charles R. Drew University of Medicine and Science (CDU), Los Angeles, CA, USA
2University of California, Los Angeles (UCLA), Los Angeles, CA, USA
3Mental Health Research Center, Tehran Institute of Psychiatry, School of Behavioral Sciences and Mental Health, Iran University of Medical Sciences, Tehran, Iran
4Keck Graduate Institute, School of Pharmacy, Claremont, CA, USA

Correspondence should be addressed to Mohsen Bazargan; ude.uwerdc@nagrazabneshom

Received 10 February 2017; Revised 4 April 2017; Accepted 12 April 2017; Published 23 May 2017

Academic Editor: F. R. Ferraro

Copyright © 2017 Mohsen Bazargan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Lochner and C. S. Cox, “Prevalence of multiple chronic conditions among Medicare beneficiaries, United States, 2010,” Preventing Chronic Disease, vol. 10, p. E61, 2013. View at Google Scholar · View at Scopus
  2. Partnership for Solutions, “Better Lives for People with Chronic Conditions,” 2006, www.partnershipforsolutions.org.
  3. C. J. Charlesworth, E. Smit, D. S. H. Lee, F. Alramadhan, and M. C. Odden, “Polypharmacy among adults aged 65 years and older in the United States: 1988–2010,” Journals of Gerontology Series A, vol. 70, no. 8, pp. 989–995, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Johnell and I. Klarin, “The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600 000 elderly patients from the Swedish prescribed drug register,” Drug Safety, vol. 30, no. 10, pp. 911–918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. E. S. Huang, “Appropriate application of evidence to the care of elderly patients with diabetes,” Current Diabetes Reviews, vol. 3, no. 4, pp. 260–263, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. B. D. Hayes, W. Klein-Schwartz, and F. Barrueto Jr., “Polypharmacy and the Geriatric Patient,” Clinics in Geriatric Medicine, vol. 23, no. 2, pp. 371–390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. E. R. Hajjar, A. C. Cafiero, and J. T. Hanlon, “Polypharmacy in elderly patients,” The American Journal of Geriatric Pharmacotherapy, vol. 5, no. 4, pp. 345–351, 2007. View at Publisher · View at Google Scholar
  8. E. Astrand, B. Åstrand, K. Antonov, and G. Petersson, “Potential drug interactions during a three-decade study period: a cross-sectional study of a prescription register [erratum appears in Eur J Clin Pharmacol. 2007 Nov;63(11):1095],” European Journal of Clinical Pharmacology, vol. 63, no. 9, pp. 851–859, 2007. View at Publisher · View at Google Scholar
  9. J. T. Hanlon, C. F. Pieper, E. R. Hajjar et al., “Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay,” Journals of Gerontology Series A, vol. 61, no. 5, pp. 511–515, 2006. View at Publisher · View at Google Scholar
  10. D. A. Gorard, “Escalating polypharmacy,” An International Journal of Medicine, vol. 99, no. 11, pp. 797–800, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. T. Cannon, M. M. Choi, and M. A. Zuniga, “Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis,” American Journal Geriatric Pharmacotherapy, vol. 4, no. 2, pp. 134–143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. I. Baena, M. J. Faus, P. C. Fajardo et al., “Medicine-related problems resulting in emergency department visits,” European Journal of Clinical Pharmacology, vol. 62, no. 5, pp. 387–393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Fulton and E. R. Allen, “Polypharmacy in the elderly: a literature review,” Journal of the American Academy of Nurse Practitioners, vol. 17, no. 4, pp. 123–132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. N. H. Ballentine, “Polypharmacy in the elderly: maximizing benefit, minimizing harm,” Critical Care Nursing Quarterly, vol. 31, no. 1, pp. 40–45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. I. Rossi, A. Young, R. Maher et al., “Polypharmacy and health beliefs in older outpatients,” American Journal Geriatric Pharmacotherapy, vol. 5, no. 4, pp. 317–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Milton and S. H. D. Jackson, “Inappropriate polypharmacy: reducing the burden of multiple medication,” Clinical Medicine, vol. 7, no. 5, pp. 514–517, 2007. View at Google Scholar · View at Scopus
  17. J. H. Flaherty, H. M. Perry III, G. S. Lynchard, and J. E. Morley, “Polypharmacy and hospitalization among older home care patients,” Journals of Gerontology Series A, vol. 55, no. 10, pp. M554–M559, 2000. View at Publisher · View at Google Scholar
  18. G. Onder, C. Pedone, F. Landi et al., “Adverse drug reactions as cause of hospital admissions: results from the Italian group of pharmacoepidemiology in the elderly (GIFA),” Journal of the American Geriatrics Society, vol. 50, no. 12, pp. 1962–1968, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. K. M. Jamsen, J. S. Bell, S. N. Hilmer et al., “Effects of changes in number of medications and drug burden index exposure on transitions between frailty states and death: the concord health and ageing in men project cohort study,” Journal of the American Geriatrics Society, vol. 64, no. 1, pp. 89–95, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. L. L. Dwyer, B. Han, D. A. Woodwell, and E. A. Rechtsteiner, “Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey,” American Journal Geriatric Pharmacotherapy, vol. 8, no. 1, pp. 63–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Rosamond, K. Flegal, K. Furie et al., “Heart disease and stroke statistics—2008 update: a report from the american heart association statistics committee and stroke statistics subcommittee,” Circulation, vol. 117, no. 4, pp. e25–e146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Wang, I. H. Zuckerman, N. A. Miller, F. T. Shaya, J. M. Noel, and C. D. Mullins, “Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites,” Health Services Research, vol. 42, no. 4, pp. 1499–1519, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. D. P. Schauer, J. A. Johnston, C. J. Moomaw, M. Wess, and M. H. Eckman, “Racial disparities in the filling of warfarin prescriptions for nonvalvular atrial fibrillation,” American Journal of the Medical Sciences, vol. 333, no. 2, pp. 67–73, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. T. L. Mark, K. J. Axelsen, L. Mucha, and Y. Sadkova, “Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients,” American Journal of Managed Care, vol. 13, no. 3, 2007. View at Google Scholar · View at Scopus
  25. J. Wang, J. M. Noel, I. H. Zuckerman, N. A. Miller, F. T. Shaya, and C. D. Mullins, “Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites,” Medical Care Research & Review, vol. 63, no. 6, pp. 742–763, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. F. Farley, R. R. Cline, and K. Gupta, “Racial variations in antiresorptive medication use: results from the 2000 Medical Expenditure Panel Survey (MEPS),” Osteoporosis International, vol. 17, no. 3, pp. 395–404, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Claxton, J. Cramer, and C. Pierce, “A systematic review of the associations between dose regimens and medication compliance,” Clinical Therapeutics, vol. 23, no. 8, pp. 1296–1310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. G. G. Fillenbaum, R. D. Horner, J. T. Hanlon, L. R. Landerman, D. V. Dawson, and H. J. Cohen, “Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population,” Journal of Clinical Epidemiology, vol. 49, no. 5, pp. 587–593, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Hussein, T. M. Waters, C. F. Chang, J. E. Bailey, L. M. Brown, and D. K. Solomon, “Impact of medicare part D on racial disparities in adherence to cardiovascular medications among the elderly,” Medical Care Research and Review, vol. 73, no. 4, pp. 410–436, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. C. A. Okoro, T. W. Strine, S. L. Young, L. S. Balluz, and A. H. Mokdad, “Access to health care among older adults and receipt of preventive services. Results from the Behavioral Risk Factor Surveillance System, 2002,” Preventive Medicine, vol. 40, no. 3, pp. 337–343, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. D. Reschovsky and L. E. Felland, “Access to prescription drugs for Medicare beneficiaries,” Tracking Report, no. 23, pp. 1–4, 2009. View at Google Scholar · View at Scopus
  32. W. Cashion, W. McClellan, G. Howard et al., “Geographic region and racial variations in polypharmacy in the United States,” Annals of Epidemiology, vol. 25, no. 6, pp. 433–438, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. S. S. Mortazavi, M. Shati, A. Keshtkar, S. K. Malakouti, M. Bazargan, and S. Assari, “Defining polypharmacy in the elderly: a systematic review protocol,” BMJ Open, vol. 6, no. 3, Article ID e010989, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Yazdanshenas, M. Bazargan, J. Smith, D. Martins, H. Motahari, and G. Orum, “Pain treatment of underserved older african americans,” Journal of the American Geriatrics Society, vol. 64, no. 10, pp. 2116–2121, 2016. View at Publisher · View at Google Scholar
  35. Department of Finance, “Population Projections (Baseline 2016),” 2017, www.dof.ca.gov/Forecasting/Demographics/Projections/documents/P_PressRelease.pdf.
  36. County of Los Angels, “SPA 6 South Area—LA County Department of Public Health,” http://publichealth.lacounty.gov/chs/spa6/index.htm.
  37. American Geriatrics Society, “American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults,” Journal of the American Geriatrics Society, vol. 60, no. 4, pp. 616–631, 2012. View at Publisher · View at Google Scholar
  38. R. Melzack, “The short-form McGill pain questionnaire,” Pain, vol. 30, no. 2, pp. 191–197, 1987. View at Publisher · View at Google Scholar · View at Scopus
  39. R. H. Dworkin, D. C. Turk, D. A. Revicki et al., “Development and initial validation of an expanded and revised version of the short-form mcgill pain questionnaire (SF-MPQ-2),” Pain, vol. 144, no. 1-2, pp. 35–42, 2009. View at Publisher · View at Google Scholar
  40. World Health Organization, 2015, www.who.int/cancer/palliative/painladder/en/.
  41. Los Angeles County Department of Public Health and Office of Health Assessment and Epidemiology, “Key Indicators of Health by service Planning Area,” March 2013.
  42. T. Johansson, M. E. Abuzahra, S. Keller et al., “Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis,” British Journal of Clinical Pharmacology, pp. 532–548, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Tommelein, E. Mehuys, I. Van Tongelen et al., “Community pharmacists’ evaluation of potentially inappropriate prescribing in older community-dwelling patients with polypharmacy: observational research based on the GheOP(3)S tool,” Journal of Public Health, 2016. View at Publisher · View at Google Scholar
  44. K. Hudhra, M. García-Caballos, E. Casado-Fernandez, B. Jucja, D. Shabani, and A. Bueno-Cavanillas, “Polypharmacy and potentially inappropriate prescriptions identified by Beers and STOPP criteria in co-morbid older patients at hospital discharge,” Journal of Evaluation in Clinical Practice, vol. 22, no. 2, pp. 189–193, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Clyne, J. A. Cooper, C. M. Hughes, T. Fahey, and S. M. Smith, “‘Potentially inappropriate or specifically appropriate?’ Qualitative evaluation of general practitioners views on prescribing, polypharmacy and potentially inappropriate prescribing in older people,” BMC Family Practice, vol. 17, no. 1, p. 109, 2016. View at Publisher · View at Google Scholar
  46. G. Nightingale, E. Hajjar, K. Swartz, J. Andrel-Sendecki, and A. Chapman, “Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer,” Journal of Clinical Oncology, vol. 33, no. 13, pp. 1453–1459, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. A. J. Davidoff, G. E. Miller, E. M. Sarpong, E. Yang, N. Brandt, and D. M. Fick, “Prevalence of potentially inappropriate medication use in older adults using the 2012 beers criteria,” Journal of the American Geriatrics Society, vol. 63, no. 3, pp. 486–500, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. A. Marcum, J. Driessen, C. T. Thorpe, W. F. Gellad, and J. M. Donohue, “Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with medicare part D,” Journal of the American Geriatrics Society, vol. 62, no. 2, pp. 244–252, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. A. B. Jena, D. Goldman, L. Weaver, and P. Karaca-Mandic, “Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims,” British Medical Journal, vol. 348, 2014, Article ID: g1393. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Lancaster, K. D. Marek, L. D. Bub, and F. Stetzer, “Medication regimens of frail older adults after discharge from home healthcare,” Home Healthcare Nurse, vol. 32, no. 9, pp. 536–542, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Hovstadius, G. Petersson, L. Hellström, and L. Ericson, “Trends in inappropriate drug therapy prescription in the elderly in Sweden from 2006 to 2013: assessment using national indicators,” Drugs and Aging, vol. 31, no. 5, pp. 379–386, 2014. View at Publisher · View at Google Scholar · View at Scopus